Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Molecular Partners AG American Depositary Shares stock

Learn how to easily invest in Molecular Partners AG American Depositary Shares stock.

Molecular Partners AG American Depositary Shares is a biotechnology business based in the US. Molecular Partners AG American Depositary Shares shares (MOLN) are listed on the NASDAQ and all prices are listed in US Dollars. Molecular Partners AG American Depositary Shares employs 145 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Molecular Partners AG American Depositary Shares

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MOLN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Molecular Partners AG American Depositary Shares stock price (NASDAQ: MOLN)

Use our graph to track the performance of MOLN stocks over time.

Molecular Partners AG American Depositary Shares shares at a glance

Information last updated 2022-01-19.
Latest market close$26.50
52-week range$9.57 - $32.04
50-day moving average $16.65
200-day moving average $18.63
Wall St. target price$39.39
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.44

Buy Molecular Partners AG American Depositary Shares shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$0
$1 per month
$5
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Public
Stocks, ETFs, Cryptocurrency
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Molecular Partners AG American Depositary Shares stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Molecular Partners AG American Depositary Shares price performance over time

Historical closes compared with the close of $26.5 from 2022-01-18

1 week (2022-01-13) -6.36%
1 month (2021-12-20) 34.18%
3 months (2021-10-20) 35.97%
6 months (2021-07-20) 35.27%
1 year (2021-01-20) 28.33%
2 years (2020-01-20) 20.73%
3 years (2019-01-18) 63.38%
5 years (2017-01-20) 33.17%

Molecular Partners AG American Depositary Shares financials

Revenue TTM $9.5 million
Gross profit TTM $-46,731,000
Return on assets TTM -23.25%
Return on equity TTM -58.23%
Profit margin 0%
Book value $3.85
Market capitalisation $855.5 million

TTM: trailing 12 months

Molecular Partners AG American Depositary Shares share dividends

We're not expecting Molecular Partners AG American Depositary Shares to pay a dividend over the next 12 months.

Molecular Partners AG American Depositary Shares share price volatility

Over the last 12 months, Molecular Partners AG American Depositary Shares's shares have ranged in value from as little as $9.57 up to $32.04. A popular way to gauge a stock's volatility is its "beta".

MOLN.US volatility(beta: 0.89)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Molecular Partners AG American Depositary Shares's is 0.8913. This would suggest that Molecular Partners AG American Depositary Shares's shares are less volatile than average (for this exchange).

To put Molecular Partners AG American Depositary Shares's beta into context you can compare it against those of similar companies.

Molecular Partners AG American Depositary Shares overview

Molecular Partners AG operates as a clinical-stage biopharmaceutical company. It is developing Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of wet age-related macular degeneration, as well as for diabetic macular edema; and MP0420, a COVID-19 antiviral therapeutic candidate to inactivate SARS-CoV-2 that is in Phase II clinical trials. The company also develops MP0310, which is in Phase I clinical trials for immuno-oncology; MP0317, a tumor-localized immune agonist that activates immune cells in the tumor, which is in Phase I clinical trials; and MP0274 that is in Phase I clinical trials for HER2-positive solid tumors. In addition, it is developing MP0423, a candidate for treating COVID-19 through a single molecule; MP0533, an immune activator for multi-specific treatment of acute myeloid leukemia; and MP0250, a multi-specific DARPin molecule that targets vascular endothelial growth factor, hepatocyte growth factor, and human serum albumin to increase half-life. Further, the company develops CD3 T-Cell targeting and peptide MHC therapeutic platforms. Molecular Partners AG has strategic partnerships with Allergan, Inc. and Amgen SA for ophthalmology; collaboration with Novartis AG to develop, manufacture, and commercialize DARPin program; and collaboration with AGC Biologics and Baccinex to support development of anti-COVID-19 program.

Frequently asked questions

What percentage of Molecular Partners AG American Depositary Shares is owned by institutions?
Currently 4.773% of Molecular Partners AG American Depositary Shares shares are held by institutions.
How many people work for Molecular Partners AG American Depositary Shares?
Latest data suggests 145 work at Molecular Partners AG American Depositary Shares.
When does the fiscal year end for Molecular Partners AG American Depositary Shares?
Molecular Partners AG American Depositary Shares's fiscal year ends in December.
Where is Molecular Partners AG American Depositary Shares based?
Molecular Partners AG American Depositary Shares's address is: Wagistrasse 14, Schlieren, Switzerland, 8952
What is Molecular Partners AG American Depositary Shares's ISIN number?
Molecular Partners AG American Depositary Shares's international securities identification number is: US60853G1067

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site